Lifemd, INC 8-K filings

LifeMD reported record subscriber growth in Q1 2026, achieving 365,000 active users while affirming full-year revenue guidance.

LifeMD, Inc. announced the appointment of Atul Kavthekar as its new Chief Financial Officer, alongside other key leadership promotions.

LifeMD, Inc. announced the closing of a new senior secured revolving credit facility with Citizens Bank, N.A., providing up to $50 million in capital for corporate development and shareholder value initiatives.

LifeMD, Inc. reported a 13% year-over-year revenue increase to $60.2 million in Q3 2025, alongside a 20% rise in adjusted EBITDA and the complete payoff of outstanding debt.

LifeMD, Inc. has rescheduled its third quarter 2025 earnings release and conference call to November 17, 2025, due to identified accounting corrections impacting prior period revenue recognition.

LifeMD, Inc. announced the sale of its majority ownership interest in WorkSimpli Software LLC for an enterprise value of approximately $65 million, sharpening its focus on virtual healthcare and pharmacy.

LifeMD, Inc. has dismissed CBIZ CPAs P.C. and appointed PricewaterhouseCoopers LLP as its new independent registered public accounting firm, citing material weaknesses in internal controls.

LifeMD, Inc. reported a 23% year-over-year increase in total revenue for Q2 2025, reaching $62.2 million, alongside a significant rise in adjusted EBITDA and full repayment of senior debt.

LifeMD, Inc. announced the appointment of Shayna Webb Dray as Chief Operating Officer, accompanied by a significant increase in her base salary and a new grant of 100,000 restricted stock units tied to time and performance milestones.

LifeMD, Inc. announced that all proposals, including the election of seven directors and the ratification of CBIZ CPAs, P.C. as its independent auditor, were approved by stockholders at its annual meeting held on June 13, 2025.

LifeMD announces a strong first quarter in 2025, marked by a 49% increase in total revenue and its first-ever quarter of positive GAAP EPS, leading to raised full-year guidance.

LifeMD, Inc. has acquired key assets from Optimal Human Health MD to expand into the women's health market, focusing on hormone health, bone density, metabolism, and long-term wellness.

LifeMD, Inc. announces the resignation of Marcum LLP as its independent auditor and the appointment of CBIZ CPAs P.C., effective April 24, 2025.

LifeMD announces a 43% year-over-year increase in consolidated revenues to $64.3 million for Q4 2024, alongside positive full-year cash flow and promising 2025 financial guidance.

LifeMD's CEO, Justin Schreiber, will receive an increased annual base salary of $500,000, effective January 1, 2025, as per a second amendment to his employment agreement.

LifeMD, Inc. reports the voluntary resignation of board member Robert Jindal, effective December 31, 2024.

Naveen Bhatia has voluntarily resigned from the LifeMD board of directors, effective October 25, 2024.

LifeMD stockholders approved an increase in shares available under the company's equity incentive plan and elected nine directors at their annual meeting on June 14, 2024.

LifeMD, Inc. has appointed Dr. Calum MacRae, a Harvard Medical School clinician and researcher, to its Board of Directors to enhance its virtual healthcare services.